Non-muscle MLCK isoforms, particularly MLCK1, are highly enriched at the perijunctional actomyosin ring in differentiated villous epithelium and play a dominant role in regulating physiological and pathological barrier dynamics, as selective MLCK1 inhibition or knockdown reduces junctional permeability (Jin and Blikslager, 2020)
Unfortunately, its druggability is low
Women typically use lower doses ( 15-30 mcg/day ) due to generally lower body weight and higher sensitivity to IGF-1
Yes volume pricing is available for research labs, universities, and bulk orders
Gender-specific guidance covering menstrual cycle changes, fertility considerations, bone density during menopause, and body composition differences